(Q67906593)

English

Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: Effects on cytokine production and suppressor cell status

scientific article published on 01 January 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838486%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: effects on cytokine production and suppressor cell status (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838486%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Clinical trial of natural human lymphocyte-derived interleukin 2 in cancer patients: Effects on cytokine production and suppressor cell status (English)

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Gerhard Ehninger

7

object named as

Ehninger G

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838486%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

author name string

G. Pawelec

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838486

6 December 2022

H. J. Lenz

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838486

6 December 2022

E. Schneider

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838486

6 December 2022

H. J. Bühring

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838486

6 December 2022

A. Rehbein

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838486

6 December 2022

P. Baumgärtner

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1838486

6 December 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1838486

6 December 2022

publication date

1 January 1991

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838486%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF02221323.pdf

Portable Document Format

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

http://link.springer.com/article/10.1007/BF02221323/fulltext.html

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

http://link.springer.com/content/pdf/10.1007/BF02221323

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Biotherapy (Dordrecht, Netherlands)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838486%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838486%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838486%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

309-318

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838486%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

https://scigraph.springernature.com/pub.10.1007/bf02221323

0 references

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

2

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Biological Activity of Recombinant Human Interleukin-2 Produced inEscherichia coli

3

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Relative cloning efficiencies and long-term propagation capacity for T cell clones of highly purified natural interleukin 2 compared to recombinant interleukin 2 in man

6

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Molecular biotherapy

7

2

44

author name string

G Pawelec

publication date

1990

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human subjects

8

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacin

11

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets

14

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients

15

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Tumour necrosis factor-alpha enhances the cytolytic and cytostatic capacity of interleukin-2 activated killer cells

21

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Natural Immunity and Cell Growth Regulation

26

7

13

author name string

E Kedar

publication date

1988

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Recombinant interleukin 2 inhibits pokeweed mitogen-induced proliferation of human adult peripheral blood and cord blood mononuclear cells

27

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Dissection of suppressor cell generation in vitro

30

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Journal of biological response modifiers

31

9

5

author name string

JA Hank

publication date

1990

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Nosocomial sepsis associated with interleukin-2.

32

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma.

33

1 reference

10.1007/BF02221323

https://api.crossref.org/works/10.1007/BF02221323

6 December 2022

Identifiers

10.1007/BF02221323

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838486%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1838486%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67906593&oldid=1785740509"